Envestnet Asset Management Inc Adma Biologics, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 60,004 shares of ADMA stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,004
Previous 35,711
68.03%
Holding current value
$1.07 Million
Previous $713,000
44.32%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$266 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$202 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.52B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...